ArticleCardiology research and practice2026
Prognostic Value of Systemic Immune-Inflammation Index (SII) in Hospital Readmission Following Acute Myocardial Infarction: A Four-Year Analysis.
Article in Cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic Value of Systemic Immune-Inflammation Index (SII) in Hospital Readmission Following Acute Myocardial Infarction: A Four-Year Analysis.Cardiology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute myocardial infarction (AMI) initiates an inflammatory response essential for cardiac repair. Several novel inflammatory markers have been identified as indicators of systemic inflammation, including the systemic immune-inflammation index (SII). This study aimed to evaluate the relationship between SII levels and readmission rates in AMI patients. Methods: This retrospective cohort study analyzed 1147 AMI patients admitted between 2019 and 2021. The optimal SII cutoff was determined as 694.3 × 10 Results: Over 4 years, 454 patients were readmitted, with higher readmission rates (34.4%) observed in the high SII group. Statistically significant differences were noted in primary outcomes, with higher SII patients experiencing increased incidence of major adverse cardiovascular events (MACEs) ( Conclusion: Although patients with high SII demonstrated higher hospital readmission rates, primarily due to recurrent MI, no statistically significant association was observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.